EUVIMEDEUVIMED entdecken
Open Access

Hybrid Immunity to SARS-CoV-2 During Pregnancy Provides More Durable Infant Antibody Responses Compared to Natural Infection Alone

Sylvia M LaCourse iD, Erica A Wetzler iD, Morgan C Aurelio iD, Jaclyn N Escudero iD, Stacy S Selke, Alexander L Greninger iD, Erin A Goecker, Sarina R Barnes, Isabel S Arnould, Ailyn C Pérez-Osorio iD, Barbra A Richardson iD, Alisa Kachikis iD und 2 weitere

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiad592 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Sylvia M LaCourse und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: COVID-19, Antibodies, Viral, SARS-CoV-2, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, CDC HHS, Merck & Co, Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hybrid immunity (infection plus vaccination) may increase maternally derived SARS-CoV-2 antibody responses and durability versus infection alone.

Methods

Prospective cohort of pregnant participants with prior SARS-CoV-2 infection (anti-nucleocapsid IgG, RT-PCR, or antigen positive) and their infants had blood collected in pregnancy, at delivery/birth, and postpartum tested for anti-spike (anti-S) IgG and neutralizing antibodies (neutAb).

Results

Among 107 participants at enrollment, 40% were unvaccinated and 60% were vaccinated (received ≥1 dose); 102 had previous SARS-CoV-2 infection in pregnancy (median, 19 weeks’ gestation); 5 were diagnosed just prior to pregnancy (median, 8 weeks). At delivery, fewer unvaccinated participants (87% anti-S IgG+, 86% neutAb) and their infants (86% anti-S IgG+, 75% neutAb) had anti-S IgG+ or neutAb compared to vaccinated participants and their infants (100%, P ≤ .01 for all). By 3–6 months postpartum, 50% of infants of unvaccinated participants were anti-S IgG+ and 14% had neutAb, versus 100% among infants of vaccinated participants (all P < .01), with lower median antibody responses (anti-S IgG log10 1.95 vs 3.84 AU/mL, P < .01; neutAb log10 1:1.34 vs 1:3.20, P = .11).

Conclusions

In pregnant people with prior SARS-CoV-2, vaccination before delivery provided more durable maternally derived antibody responses than infection alone in infants through 6 months.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Antibodies, ViralSARS-CoV-2Pregnancy Complications, InfectiousImmunoglobulin GAntibodies, NeutralizingHumansPregnancyFemaleAdultProspective StudiesInfant, NewbornImmunity, Maternally-AcquiredCOVID-19 VaccinesVaccinationInfantAntibody FormationSpike Glycoprotein, CoronavirusYoung Adult

Stichwörter der Autor:innen

SARS-CoV-2hybrid immunityimmunizationpregnancytransplacental transfer

Substanzen

Antibodies, ViralImmunoglobulin GAntibodies, NeutralizingCOVID-19 VaccinesSpike Glycoprotein, Coronavirus

Autor:innen und Institutionen

  • Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.
  • Department of Global Health, University of Washington, Seattle, Washington, USA.
  • Department of Epidemiology, University of Washington, Seattle, Washington, USA.
  • Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
  • Department of Biostatistics, University of Washington, Seattle, Washington, USA.
  • Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA.

ORCID-Profile: Sylvia M LaCourse, Erica A Wetzler, Morgan C Aurelio, Jaclyn N Escudero, Alexander L Greninger, Ailyn C Pérez-Osorio, Barbra A Richardson, Alisa Kachikis, Janet A Englund, Alison L Drake

Förderung

  • NIAID NIH HHS
  • CDC HHS
  • Merck & Co, Inc
  • Centers for Disease Control and Prevention
  • NIH

Zitieren

APA

LaCourse, S. M., Wetzler, E. A., Aurelio, M. C., Escudero, J. N., Selke, S. S., Greninger, A. L., Goecker, E. A., Barnes, S. R., Arnould, I. S., Pérez-Osorio, A. C., Richardson, B. A., Kachikis, A., Englund, J. A., & Drake, A. L. (2024). Hybrid Immunity to SARS-CoV-2 During Pregnancy Provides More Durable Infant Antibody Responses Compared to Natural Infection Alone. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad592

Vancouver

LaCourse SM, Wetzler EA, Aurelio MC, Escudero JN, Selke SS, Greninger AL, et al. Hybrid Immunity to SARS-CoV-2 During Pregnancy Provides More Durable Infant Antibody Responses Compared to Natural Infection Alone. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad592

BibTeX
@article{LaCourse2024,
  author = {LaCourse, Sylvia M and Wetzler, Erica A and Aurelio, Morgan C and Escudero, Jaclyn N and Selke, Stacy S and Greninger, Alexander L and Goecker, Erin A and Barnes, Sarina R and Arnould, Isabel S and Pérez-Osorio, Ailyn C and Richardson, Barbra A and Kachikis, Alisa and Englund, Janet A and Drake, Alison L},
  title = {Hybrid Immunity to SARS-CoV-2 During Pregnancy Provides More Durable Infant Antibody Responses Compared to Natural Infection Alone},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiad592}
}
Kostenlos starten →